ArticleHepatology communications2022

HCV direct acting antiviral treatment leads to highly durable rates of ALT and AST lower than 30/19 criteria and improved APRI and FIB-4 scores.

Tung Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.